Improvement of the clinical outcome in patients with resectable pancreatic carcinoma through an intensified adjuvant treatment with gemcitabine, cisplatin and regional deep hyperthermia as compared to standard chemotherapy.
| Condition | Resected Pancreatic Adenocarcinoma |
|---|---|
| Treatment | Gemcitabine + Cisplatin + regional hyperthermia, Gemcitabine + Capecitabine |
| Clinical Study Identifier | NCT01077427 |
| Sponsor | Klinikum der Universitaet Muenchen, Grosshadern |
| Last Modified on | 10 June 2023 |
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!
No annotations made yet
Congrats! You have your own personal workspace now.